References
- Elvin A. T., Keenaghan J. B., Byrnes E. W., Tenthorey P. A., McMaster P. D., Takman B. H., Lalka D., Meyer M. B., Ronfield R. A. Tocainide conjugation in humans: novel biotransformation pathway for a primary amine. Journal of Pharmaceutical Sciences 1980; 69: 47–49
- Leandri G., Mangini A., Montanari F., Passerini R. Ricerche sugli eterociclici: spettri di assortimento U.V. e proprietà cromoforiche—nota I: Imidazoli, benzimidazoli e fenilbenzimidazoli. Gazzetta Chimica Italiana 1955; 85: 769–794
- Schmitt R., Kleinbloesem C. H., Belz G. G. Ro 40–5967, a calcium antagonist of a new generation?. European Journal of Clinical Pharmacology 1989; 36(Suppl)A336
- Tremaine L. M., Strroh J. G., Ronfield R. A. Characterization of a carbamic ester glucuronide of the secondary amine sertraline. Drug Metabolism and Disposition 1989; 17: 58–63
- Welker H. A., Eggers H., Kleinbloesem C., Erb K., Breithaupt K., Butzer R., Belz G. G. Ro 40–5967: pharmacokinetics of a new calcium antagonist. European Journal of Clinical Pharmacology 1989; 36(Suppl)A304
- v d Wildenberg H. M., Delbressine L. P. C., Kasperson F. M., Wagenaars G. N., Jacobs P. L. Biotransformation of trans-5-chloro-2-methyl-2,3,3a,12b-tetrahydro-1H-dibenz[2,3:6,7]oxepino [4,5-c]pyrrolidine maleate in rats. Arzneimittel Forschung 1990; 40: 540–544